NovoNutrients bags $18m in Series A to transform CO₂ into nutritional proteins
NovoNutrients, a biotech innovator specializing in converting CO₂ emissions into high-quality protein, announced a successful first closing of its Series A financing. The funding round ... Read More
Aptamer Group wins new contracts with global pharmaceutical leaders
Aptamer Group plc (AIM: APTA), an innovator in the life sciences sector, has announced new agreements worth up to £275,000 for the development of its ... Read More
ANGLE plc collaborates with AstraZeneca on cutting-edge cancer detection technology
ANGLE plc, a leading innovator in liquid biopsy and circulating tumour cell (CTC) solutions, has announced a significant supplier agreement with global biopharmaceutical leader AstraZeneca ... Read More
NanoString Technologies strikes deal with Patient Square Capital amid bankruptcy proceedings
In a significant move, NanoString Technologies, Inc. (OTC: NSTGQ), a pioneer in life science tools for discovery and translational research, has announced an agreement with ... Read More